Double Bond Pharmaceutical International AB (XSAT:DBP B) Net Interest Margin (Bank Only) %

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSAT:DBP B Double Bond Pharmaceutical International AB XSAT:DBP B
30 GF Score
Price kr0.14
GF Value kr0.06
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Double Bond Pharmaceutical International AB Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

XSAT:DBP B
30GF Score
Double Bond Pharmaceutical International AB XSAT:DBP B
Net Interest Margin (Bank Only) % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Double Bond Pharmaceutical International AB (XSAT:DBP B) Overvalued in 2026?

Based on GuruFocus' analysis, Double Bond Pharmaceutical International AB stock appears to be overvalued. The current stock price of kr0.14 is trading 125.8% above its estimated GF Value™ of kr0.06. GuruFocus considers Double Bond Pharmaceutical International AB to be Significantly Overvalued.

Key valuation signals for XSAT:DBP B:

  • Net Interest Margin (Bank Only) %:
  • GF Value™: kr0.06 vs. price of kr0.14 (125.8% above fair value)
  • GF Score™: 30/100 with 3 warning signs

No single metric tells the full story. See the XSAT:DBP B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Double Bond Pharmaceutical International AB Business Description

Address Virdings Alle 32B, Uppsala, SWE, 75450
Double Bond Pharmaceutical International AB is a pharmaceutical company. The company develops and commercializes approaches for the treatment of cancers, infections, autoimmune diseases, and other life-threatening disorders.
30GF Score

Get the complete analysis for XSAT:DBP B

Net Interest Margin (Bank Only) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.14
Price
kr0.06
GF Value